CGEM
USDCullinan Therapeutics Inc. Common Stock
即時價格
價格圖表
關鍵指標
市場指標
開盤
$7.800
最高
$7.800
最低
$7.360
交易量
0.61M
公司基本面
市值
437.2M
行業
生物科技
國家
United States
交易統計
平均交易量
0.89M
交易所
NMS
貨幣
USD
52週範圍
相關新聞
Cullinan Therapeutics to Showcase New Data Demonstrating Compelling Clinical Activity for CLN-049, a Novel FLT3xCD3 T Cell Engager, in AML Patients in an Oral Presentation at the 67th ASH Annual Meeting
CLN-049 demonstrated anti-leukemic activity, including multiple complete responses, in a heavily pretreated population of patients with r/r AML, regardless of FLT3 mutational status ~30% CRc rate observed at clinically
Cullinan Therapeutics Shares Additional Preclinical B Cell Depletion Data for CLN-978, Supporting Clinical Development Across Multiple Autoimmune Diseases, at ACR Convergence 2025
CLN-978 led to rapid and deep B cell depletion in vitro and in vivo in multiple autoimmune diseases CAMBRIDGE, Mass., Oct. 25, 2025 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (NASDAQ:CGEM), a clinical-stage
相關股票
TTWO
Take-Two Interactive Software Inc.
GENE
Genetic Technologies Ltd ADS
AIZN
Assurant Inc. 5.25% Subordinated Notes due 2061
CMAXW
CareMax Inc. Warrant
ATHE
Alterity Therapeutics Limited American Depositary Shares
保持更新
設定價格提醒，獲取AI分析更新和即時市場新聞。